Lenferink A E, Kramer R H, van Vugt M J, Königswieser M, Di Fiore P P, van Zoelen E J, van de Poll M L
Department of Cell Biology, University of Nijmegen, Toernooiveld 1, 6525 ED Nijmegen, The Netherlands.
Biochem J. 1997 Nov 1;327 ( Pt 3)(Pt 3):859-65. doi: 10.1042/bj3270859.
Human epidermal growth factor (EGF) and human transforming growth factor alpha (TGF-alpha) are structurally related polypeptide growth factors that exert their mitogenic activity through interaction with a common cell-surface receptor, the epidermal growth factor receptor (EGFR). The biological effect induced by these two ligands is quantitatively similar in most cases; in some test systems, however, TGF-alpha functions as a more potent form of EGF. In this study, we have compared EGF, TGF-alpha and ten previously described chimaeras of these two ligands in terms of their ability to generate a mitogenic response in cells carrying the human EGFR, and observed that three of the mutant growth factors (E3T, E4T and T3E4T) are mitogenic at concentrations 10-fold lower than that of either wild-type EGF or TGF-alpha. No difference in tyrosine kinase activity of the receptor towards an external substrate was observed after binding of the various mutants. It has been established before [Ebner and Derynck (1991) Cell Regulation 2, 599-612] that EGF and TGF-alpha differ in the processing of the receptor-ligand complex after internalization, as a result of their different pH sensitivities of receptor binding. Similar measurements on our chimaeric mutants revealed that the above superagonists show an enhanced pH dependence of binding in comparison with EGF. Furthermore, induction of receptor recycling by these superagonists is largely comparable with that induced by TGF-alpha. No superagonistic behaviour was observed on a cell-line containing an EGFR/erbB-2 chimaera which does not show ligand-induced internalization. These data show that EGF/TGFalpha chimaeras can be more active than the naturally occurring ligands, and that receptor recycling after ligand-induced internalization seems to be a prerequisite for this phenomenon.
人表皮生长因子(EGF)和人转化生长因子α(TGF-α)是结构相关的多肽生长因子,它们通过与共同的细胞表面受体——表皮生长因子受体(EGFR)相互作用来发挥其促有丝分裂活性。在大多数情况下,这两种配体诱导的生物学效应在数量上是相似的;然而,在一些测试系统中,TGF-α的功能相当于一种更有效的EGF形式。在本研究中,我们比较了EGF、TGF-α以及之前描述的这两种配体的十种嵌合体在携带人EGFR的细胞中产生促有丝分裂反应的能力,并观察到三种突变生长因子(E3T、E4T和T3E4T)在浓度比野生型EGF或TGF-α低10倍时仍具有促有丝分裂活性。在结合各种突变体后,未观察到受体对外部底物的酪氨酸激酶活性有差异。之前已经确定[埃布纳和德林克(1991年)《细胞调节》2,599 - 612],由于EGF和TGF-α受体结合的pH敏感性不同,它们在内化后受体 - 配体复合物的处理方式存在差异。对我们的嵌合突变体进行的类似测量表明,与EGF相比,上述超级激动剂显示出结合的pH依赖性增强。此外,这些超级激动剂诱导受体再循环的程度与TGF-α诱导的程度基本相当。在含有EGFR/erbB - 2嵌合体且不显示配体诱导内化的细胞系中未观察到超级激动行为。这些数据表明,EGF/TGFα嵌合体可能比天然存在的配体更具活性,并且配体诱导内化后的受体再循环似乎是这种现象的一个先决条件。